GGrantIndex
Sort

64,565 grants matching drug discovery

Tackling Undruggable Cancer Targets using Chemoproteomic Platforms

$928,230
Daniel Nomura · University Of California Berkeley · R35 · FY2022 · CA

NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE

$927,749
University Of Virginia Charlottesville · U19 · FY2003 · CA

Genes contributing for nicotine dependence in humans

$927,544
Kari Stefansson · Decode Genetics, Ehf · R01 · FY2014 · DA

Near-IR Photorelease Chemistry: Discovery and Applications

$927,472
Martin Schnermann · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Genomic characterization and development of therapies for pediatric sarcoma

$927,446
John Shern · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Topical Microbicides for Prevention of STDs/HIV

$927,387
Magee-Women'S Res Inst And Foundation · P01 · FY2002 · AI

Center for Genomics and Healthcare Equality

$927,353
Wylie G Burke · University Of Washington · P50 · FY2013 · HG

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$926,839
Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Identifying novel anti-infectives by high through-put screening in whole animals

$926,799
Frederick M Ausubel · Massachusetts General Hospital · R01 · FY2010 · AI

Integrated photoacoustic and fluorescence imaging system for anatomical, functional, and molecular characterization of murine models

$926,753
Hans-Peter Franz Brecht · Photosound Technologies, Inc. · R44 · FY2023 · OD

Project 3 - Flavivirus - UTMB

$926,569
Pei-Yong Shi · University Of Alabama At Birmingham · U19 · FY2021 · AI

A 600 MHz NMR spectrometer upgrade for the Sanford Burnham Prebys Cancer Center

$926,277
Francesca M Marassi · Sanford Burnham Prebys Medical Discovery Institute · S10 · FY2020 · OD

Defining and Controlling Airway Disease

$926,100
Michael Jay Holtzman · Washington University · R35 · FY2024 · HL

First-in-class ETS inhibitor TK216: Translational Biology and Oral Dosage Form Development

$925,560
Gunnar Joerg Floris Kaufmann · Oncternal Therapeutics, Inc. · R44 · FY2021 · CA

Combined Computational and Cardiac Microphysiological System Approach for Drug-Induced Proarrhythmia Screening

$925,511
Samuel Wall · Organos, Inc. · R44 · FY2020 · HL

The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)

$925,466
Robert E Braun · Jackson Laboratory · UM1 · FY2020 · OD

Identifying Genetic Variants Associated with Opioid Overdose Mortality

$925,217
Elliot C Nelson · Washington University · R01 · FY2019 · DA

Kentucky Center for Clinical and Translational Science

$925,132
Philip A Kern · University Of Kentucky · UL1 · FY2018 · TR

An Innovative Approach to Identify Correctors of Metabolic Complications in HIV

$925,072
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2025 · DK

Regulation of Hormone Receptors and Gonadal Genes

$925,039
Maria Dufau Catt · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer

$924,971
John B Sunwoo · Stanford University · U01 · FY2017 · DE

Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer

$924,971
John B Sunwoo · Stanford University · U01 · FY2018 · DE

Genomic Studies of the Impact of External Factors on Parasite Development and Disease Outcome

$924,968
Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2021 · AI

Collaborative Research: RECODE: Directing and Controlling Cardiac Differentiation Through Cellular and Microenvironmental Manipulation and Application of Machine-Learning

$924,660
Elizabeth A Lipke · Auburn University · · FY2021 · ENG

Targeting Mutant KRAS for Cancer Therapy

$924,613
Said M Sebti · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2018 · CA